Description

Diclak ID (diclofenac) Tablets 75 mg.

Diclak ID tablets are a medication containing 75 mg. of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) known for its analgesic and anti-inflammatory properties. Each package contains 100 tablets, providing a convenient and effective treatment option for various conditions.

Overview

Diclofenac is a widely used medication for the management of pain and inflammation associated with various conditions such as arthritis, musculoskeletal disorders, and postoperative pain. It belongs to the class of NSAIDs, which work by inhibiting the production of prostaglandins, substances in the body that are responsible for pain and inflammation.

Indications

Diclak ID tablets are indicated for the treatment of the following conditions:

• Arthritis (rheumatoid arthritis, osteoarthritis)
• Ankylosing spondylitis
• Acute gout
• Musculoskeletal disorders
• Postoperative pain

Dosage and Administration

The usual recommended dose of Diclak ID tablets is 75 mg. taken once daily with food to minimize the risk of gastrointestinal side effects. The dosage may be adjusted based on the severity of the condition and individual response to treatment. It is important to follow the instructions provided by your healthcare provider or as indicated on the package.

Contraindications

Diclak ID tablets are contraindicated in individuals with a known hypersensitivity to diclofenac or other NSAIDs. It should not be used in patients with a history of allergic reactions, asthma, gastrointestinal bleeding, or severe kidney or liver impairment. Pregnant women in the third trimester should also avoid using diclofenac due to potential risks to the fetus.

Warnings and Precautions

Before using Diclak ID tablets, it is important to consider the following warnings and precautions:

• Cardiovascular risk: NSAIDs may increase the risk of heart attack or stroke, especially in patients with preexisting cardiovascular conditions.
• Gastrointestinal effects: Diclofenac can cause ulcers, bleeding, or perforation of the stomach or intestines, particularly in elderly patients.
• Renal impairment: NSAIDs may cause or worsen kidney function, especially in patients with preexisting renal conditions.
• Hepatic effects: Liver function should be monitored in patients taking diclofenac, as it can cause liver damage in rare cases.
• Fluid retention: Diclofenac may cause fluid retention and edema, especially in patients with heart failure or hypertension.

Adverse Reactions

Common adverse reactions associated with the use of diclofenac include gastrointestinal disturbances (such as nausea, indigestion, and abdominal pain), headache, dizziness, and rash. Serious side effects such as gastrointestinal bleeding, cardiovascular events, and liver toxicity may occur rarely and require immediate medical attention.

Drug Interactions

Diclofenac may interact with other medications, potentially affecting their efficacy or increasing the risk of side effects. It is important to inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal supplements, to avoid potentially harmful interactions.

Storage

Store Diclak ID tablets in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children and pets. Do not use the medication past the expiration date indicated on the package.

Conclusion

Diclak ID tablets containing 75 mg. of diclofenac are a valuable treatment option for pain and inflammation associated with various conditions. When used as directed and under the supervision of a healthcare provider, diclofenac can provide effective relief and improve the quality of life for individuals suffering from arthritis, musculoskeletal disorders, and postoperative pain.

It is essential to follow the recommended dosage and precautions to minimize the risk of adverse effects and drug interactions. If you experience any concerning symptoms or side effects while taking Diclak ID tablets, consult your healthcare provider promptly for further evaluation and management.